Thermo Fisher Scientific (TMO) Cash from Investing Activities Growth (1y) (2010 - 2026)
Thermo Fisher Scientific (TMO) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 209.29 Bn | 205.35 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 137.39 Bn | 133.06 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.84 Bn | 46.64 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.29 Bn | 37.48 Bn | 990.00 Mn | 32.46% |
| 5 | Natera | 39.28 Bn | 38.18 Bn | 696.04 Mn | -91.12% |
| 6 | Iqvia Holdings | 37.90 Bn | 35.95 Bn | 1.44 Bn | -10.12% |
| 7 | Illumina | 30.65 Bn | 29.49 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.92 Bn | 28.87 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 25.96 Bn | 25.64 Bn | 1.03 Bn | -8.06% |
| 10 | Labcorp Holdings | 25.71 Bn | 24.73 Bn | 1.01 Bn | 4.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 156.94% |
| Mar 28, 2026 | -1,600.38% |
| Dec 31, 2025 | 4,355.00% |
| Sep 27, 2025 | -15.23% |
| Jun 28, 2025 | -13.83% |
| Mar 29, 2025 | 74.04% |
| Dec 31, 2024 | 105.32% |
| Sep 28, 2024 | -202.96% |
| Jun 29, 2024 | 42.89% |
| Mar 30, 2024 | 35.39% |
| Dec 31, 2023 | 28.38% |
| Sep 30, 2023 | -116.70% |
| Jul 1, 2023 | -5.73% |
| Apr 1, 2023 | -368.96% |
| Dec 31, 2022 | 97.19% |
| Oct 1, 2022 | 11.53% |
| Jul 2, 2022 | 33.07% |
| Apr 2, 2022 | 66.47% |
| Dec 31, 2021 | -2,885.94% |
| Oct 2, 2021 | -68.77% |